Under “Source information," do I need to include commercial sources from which I obtain somatic cells?

ESCRO does not review the use of somatic cells unless the investigator plans to induce pluripotency and manipulate the hESC-like line further in vivo, in which case provenance documentation is needed.  Therefore, with this one exception, the ESCRO application does not require you to list sources of somatic cells.